Search Page

1

Cite

Share

Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study.

Desai D, Khan AR, Soneja M, Mittal A, Naik S, Kodan P, Mandal A, Maher GT, Kumar R, Agarwal A, Gowda NR, H V, Kumar P, Pandey S, Pandey RM, Kumar A, Ray A, Jorwal P, Nischal N, Choudhary A, Brijwal M, Madan K, Lodha R, Sinha S, Dar L, Wig N, Guleria R. Desai D, et al. Lancet Infect Dis. 2022 Mar;22(3):349-356. doi: 10.1016/S1473-3099(21)00674-5. Epub 2021 Nov 23. Lancet Infect Dis. 2022. PMID: 34826383 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy.

Rayati Damavandi A, Dowran R, Al Sharif S, Kashanchi F, Jafari R. Rayati Damavandi A, et al. Med Microbiol Immunol. 2022 Jun;211(2-3):79-103. doi: 10.1007/s00430-022-00729-6. Epub 2022 Mar 2. Med Microbiol Immunol. 2022. PMID: 35235048 Free PMC article. Review.

Cite

Share

3

Cite

Share

Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review.

Hayawi K, Shahriar S, Serhani MA, Alashwal H, Masud MM. Hayawi K, et al. Vaccines (Basel). 2021 Nov 10;9(11):1305. doi: 10.3390/vaccines9111305. Vaccines (Basel). 2021. PMID: 34835238 Free PMC article. Review.

Cite

Share

4

Cite

Share

Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac.

Nantanee R, Aikphaibul P, Jaru-Ampornpan P, Sodsai P, Himananto O, Theerawit T, Sophonphan J, Tovichayathamrong P, Manothummetha K, Laohasereekul T, Hiransuthikul N, Hirankarn N, Puthanakit T; Study Team. Nantanee R, et al. Vaccine. 2022 May 26;40(24):3320-3329. doi: 10.1016/j.vaccine.2022.04.067. Epub 2022 May 2. Vaccine. 2022. PMID: 35513961 Free PMC article.

Cite

Share

5

Cite

Share

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.

Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Fiolet T, et al. Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27. Clin Microbiol Infect. 2022. PMID: 34715347 Free PMC article. Review.

Cite

Share

6

Cite

Share

The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance.

Soh SM, Kim Y, Kim C, Jang US, Lee HR. Soh SM, et al. J Microbiol. 2021 Sep;59(9):807-818. doi: 10.1007/s12275-021-1348-5. Epub 2021 Aug 27. J Microbiol. 2021. PMID: 34449057 Free PMC article. Review.

Cite

Share

7

Cite

Share

Vaccines for COVID-19: Where do we stand in 2021?

Sharma K, Koirala A, Nicolopoulos K, Chiu C, Wood N, Britton PN. Sharma K, et al. Paediatr Respir Rev. 2021 Sep;39:22-31. doi: 10.1016/j.prrv.2021.07.001. Epub 2021 Jul 12. Paediatr Respir Rev. 2021. PMID: 34362666 Free PMC article. Review.

Cite

Share

8

Cite

Share

Opposing Mechanisms Involving Perceived Benefits versus Safety Partially Explained an Increase in COVID-19 Vaccination Intention among Unvaccinated Chinese Adults during a Post-Rollout Period: Results of Two Serial Surveys.

Yu Y, Lau JTF, Lau MMC. Yu Y, et al. Vaccines (Basel). 2021 Nov 30;9(12):1414. doi: 10.3390/vaccines9121414. Vaccines (Basel). 2021. PMID: 34960160 Free PMC article.

Cite

Share

9

Cite

Share

Analysis of efficacy of intervention strategies for COVID-19 transmission: A case study of Hong Kong.

Zhang N, Jack Chan PT, Jia W, Dung CH, Zhao P, Lei H, Su B, Xue P, Zhang W, Xie J, Li Y. Zhang N, et al. Environ Int. 2021 Nov;156:106723. doi: 10.1016/j.envint.2021.106723. Epub 2021 Jun 18. Environ Int. 2021. PMID: 34161908 Free PMC article.

Cite

Share

10

Cite

Share

Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival.

Sevinc SA, Metin S, Basi NB, Ling J, Cinar AS, Oba S. Sevinc SA, et al. Epidemiol Infect. 2022 Feb 9;150:e35. doi: 10.1017/S0950268822000267. Epidemiol Infect. 2022. PMID: 35135644 Free PMC article.

Cite

Share